Presidents have played an important and sometimes surprising role in driving regulatory changes.

With 26.6% of the European market share in 2022, the U.K. is recognized as a lucrative market for cell therapy manufacturing. Support from regulatory bodies like the European Medicines Agency (EMA) ...

Opinion: Perkins Coie’s Shylah Alfonso and Christopher Williams write that labor markets and artificial intelligence likely ...